Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole Pharmacokinetics in Obese Subjects (FOLIA)
NCT04122560Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2019
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label trial of fluconazole in candidiasis and invasive fungal infection (IFI) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Area under the plasma concentration versus time curve of fluconazole at 48 hours. Started Nov 2019; status: completed.
02
Drugs
fluconazole
03
Conditions
candidiasisinvasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT04122560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04122560.